On September 29, 2020, Value Capital Trust announced the termination of its previously announced letter of intent with neuroLytixs Inc. The Trust is continuing to identify and evaluate assets and businesses with a view to completing its Qualifying Transaction (as such term is defined in the policies of the TSX Venture Exchange).